AUVI Stock: 13 Things to Know About Applied UV and the Airocide System

Applied UV (NASDAQ:AUVI) is in the news Tuesday as shares of AUVI stock soar after announcing its acquisition of Akida Holdings.

woman in a white shirt wearing a face mask while at an airport

Source: Maridav / Shutterstock

Here’s everything investors need to know about AUVI stock and what the recent deal means for it.

  • Applied UV is a company focused on developing and acquiring tech that can reduce infection in healthcare, hospitality, commercial and municipal settings.
  • It mainly does so through its subsidiaries SteriLumen and Munn Works.
  • This has it making use of ultraviolet light to destroy pathogens.
  • This means it is effective at killing the human coronavirus.
  • The novel coronavirus behind the current pandemic is of a similar genetic structure to the human one.
  • As such, ultraviolet light is also effective at killing it.
  • SteriLumen is specifically the subsidiary that acquired Akida Holdings.
  • The purchase was funded with 1.375 million of AUVI stock and $901,274.96 in cash.
  • The estimated revenue reported by Akida Holdings in 2020 was $4.7 million.
  • Akida Holdings is the maker of the patented Airocide System for air disinfection and purification.
  • This is a device that uses ultraviolet light and a proprietary titanium dioxide-based photocatalyst to kill airborne pathogens.
  • The U.S. Army is among the organizations that are making use of the Airocide System.
  • The Airocide System was initially developed for NASA by the University of Wisconsin.

AUVI stock was up 358% as of noon Tuesday.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Article printed from InvestorPlace Media,

©2022 InvestorPlace Media, LLC